Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Cell Free Protein Synthesis

Cell Free Protein Synthesis Designed for AI Drug Discovery Home » Protein Expression » Cell Free Protein Expression Overview In a market with few specialized providers, GenScript’s cell free protein synthesis platform empowers AI-driven protein discovery by of

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Cell Free Protein Synthesis

Designed for AI Drug Discovery

Home » Protein Expression » Cell Free Protein Expression

Overview

In a market with few specialized providers, GenScript’s cell free protein synthesis platform empowers AI-driven protein discovery by offering a competitive edge. While in-house protein expression often incurs high costs and operational bottlenecks, our end-to-end services deliver:

* Compared to conventional methods, based on average cost from open source and customer feedback.

As Fast As 5 Business Days

from sequence to protein

Screen 2-3x More Candidates

with the same budget*

Large Capacity Optimized for HTP Screening

1000+ samples per day

TurboCHO™ High Throughput Services Upgraded to 2.0 Version

TurboCHO™ Express Services

TurboCHO™ High Performance Services

TurboCHO™ Stable Cell Pool & Cell Line

TurboCHO™ Protein Expression Kit New

TurboCHO™ SmartQuote Tool New

TurboCHO™ Antibody Expression in Singapore

TurboCHO™ Bi-specific Antibody Expression

End-to-End Solutions: HTP to Custom Development

CRISPR/Cas Protein ProductionNew

Custom GMP-Grade Bacterial Protein Expression

Insect Expression

Mammalian Expression

Cell Free Protein Expression

BLI & SPR Real-time Affinity Measurement Services

Cell Free Expression Workflows

Created in https://BioRender.com

Service Specification

VHH - His

1 ml (Target yield 10-200 μg)

5 Business Days

Target Protein, CoA Report (A280, SDS-PAGE)

5 ml (Target yield 100-1000 μg)

Other format

1/5 mL

Pre-evaluation

1. Timeline varies based on sample size.

VHH-His1

1mL Supernatant

6 Business Days

BLI Binding Report

1. Other formats needs pre-evaluation. 2. Timeline varies based on sample size.

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →